Click for best price
Postpemic Era Lung Cancer Liquid Biopsy Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Lung Cancer Liquid Biopsy Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Lung Cancer Liquid Biopsy industry at home and abroad, estimate the overall market scale of the Lung Cancer Liquid Biopsy industry and the market share of major countries, Lung Cancer Liquid Biopsy industry, and study and judge the downstream market demand of Lung Cancer Liquid Biopsy through systematic research, Analyze the competition pattern of Lung Cancer Liquid Biopsy, so as to help solve the pain points of various stakeholders in Lung Cancer Liquid Biopsy industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Lung Cancer Liquid Biopsy Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Lung Cancer Liquid Biopsy Market?
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Major Type of Lung Cancer Liquid Biopsy Covered in XYZResearch report:
Exosomes and RNA
CTCs and ctDNA
Application Segments Covered in XYZResearch Market
Hospitals
Clinics
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Lung Cancer Liquid Biopsy Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
92 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Lung Cancer Liquid Biopsy Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Lung Cancer Liquid Biopsy Market by Value
2.2.1 Global Lung Cancer Liquid Biopsy Revenue by Type
2.2.2 Global Lung Cancer Liquid Biopsy Market by Value
2.3 Global Lung Cancer Liquid Biopsy Market by Sales
2.3.1 Global Lung Cancer Liquid Biopsy Sales by Type
2.3.2 Global Lung Cancer Liquid Biopsy Market by Sales
3. The Major Driver of Lung Cancer Liquid Biopsy Industry
3.1 Historical & Forecast Global Lung Cancer Liquid Biopsy Sales and Revenue (2018-2028)
3.2 Largest Application for Lung Cancer Liquid Biopsy (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Lung Cancer Liquid Biopsy Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Lung Cancer Liquid Biopsy Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Lung Cancer Liquid Biopsy Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Lung Cancer Liquid Biopsy Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Lung Cancer Liquid Biopsy Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Lung Cancer Liquid Biopsy Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Lung Cancer Liquid Biopsy Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Lung Cancer Liquid Biopsy Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Lung Cancer Liquid Biopsy Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Lung Cancer Liquid Biopsy Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Lung Cancer Liquid Biopsy Average Price Trend
13.1 Market Price for Each Type of Lung Cancer Liquid Biopsy in US (2018-2022)
13.2 Market Price for Each Type of Lung Cancer Liquid Biopsy in Europe (2018-2022)
13.3 Market Price for Each Type of Lung Cancer Liquid Biopsy in China (2018-2022)
13.4 Market Price for Each Type of Lung Cancer Liquid Biopsy in Japan (2018-2022)
13.5 Market Price for Each Type of Lung Cancer Liquid Biopsy in India (2018-2022)
13.6 Market Price for Each Type of Lung Cancer Liquid Biopsy in Korea (2018-2022)
13.7 Market Price for Each Type of Lung Cancer Liquid Biopsy in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Lung Cancer Liquid Biopsy in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Lung Cancer Liquid Biopsy Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Lung Cancer Liquid Biopsy
15. Lung Cancer Liquid Biopsy Competitive Landscape
15.1 RainDanceTechnologies
15.1.1 RainDanceTechnologies Company Profiles
15.1.2 RainDanceTechnologies Product Introduction
15.1.3 RainDanceTechnologies Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Biocartis
15.2.1 Biocartis Company Profiles
15.2.2 Biocartis Product Introduction
15.2.3 Biocartis Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Qiagen
15.3.1 Qiagen Company Profiles
15.3.2 Qiagen Product Introduction
15.3.3 Qiagen Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Guardant Health
15.4.1 Guardant Health Company Profiles
15.4.2 Guardant Health Product Introduction
15.4.3 Guardant Health Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 MDxHealth
15.5.1 MDxHealth Company Profiles
15.5.2 MDxHealth Product Introduction
15.5.3 MDxHealth Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Pathway Genomics
15.6.1 Pathway Genomics Company Profiles
15.6.2 Pathway Genomics Product Introduction
15.6.3 Pathway Genomics Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 NeoGenomics Laboraories
15.7.1 NeoGenomics Laboraories Company Profiles
15.7.2 NeoGenomics Laboraories Product Introduction
15.7.3 NeoGenomics Laboraories Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Sysmex Inostics
15.8.1 Sysmex Inostics Company Profiles
15.8.2 Sysmex Inostics Product Introduction
15.8.3 Sysmex Inostics Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Cynvenio
15.9.1 Cynvenio Company Profiles
15.9.2 Cynvenio Product Introduction
15.9.3 Cynvenio Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Menarini Silicon Biosystems
15.10.1 Menarini Silicon Biosystems Company Profiles
15.10.2 Menarini Silicon Biosystems Product Introduction
15.10.3 Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 Adaptive Biotechnologies
15.12 Biocept
15.13 Angle plc
16. Conclusion
17. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Sales by Application of Lung Cancer Liquid Biopsy Industry (Volume)
Figure 2. Lung Cancer Liquid Biopsy Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biopsy Revenue in 2022
Figure 5. US Lung Cancer Liquid Biopsy Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Lung Cancer Liquid Biopsy Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Lung Cancer Liquid Biopsy Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Lung Cancer Liquid Biopsy Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Lung Cancer Liquid Biopsy Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Lung Cancer Liquid Biopsy Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Lung Cancer Liquid Biopsy Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Lung Cancer Liquid Biopsy Revenue, by Type (Million USD) (2018-2028)
Table 4. Lung Cancer Liquid Biopsy Sales, by Type (K Unit) (2018-2028)
Table 5. Lung Cancer Liquid Biopsy Sales (K Unit) by Application (2018-2028)
Table 6. Lung Cancer Liquid Biopsy Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Lung Cancer Liquid Biopsy Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Lung Cancer Liquid Biopsy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Lung Cancer Liquid Biopsy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Lung Cancer Liquid Biopsy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Lung Cancer Liquid Biopsy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Lung Cancer Liquid Biopsy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Lung Cancer Liquid Biopsy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Lung Cancer Liquid Biopsy Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biopsy in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. RainDanceTechnologies Profiles
Table 61. RainDanceTechnologies Lung Cancer Liquid Biopsy Product Introduction
Table 62. RainDanceTechnologies Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. RainDanceTechnologies Strategic initiatives
Table 64. Biocartis Profiles
Table 65. Biocartis Lung Cancer Liquid Biopsy Product Introduction
Table 66. Biocartis Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Biocartis Strategic initiatives
Table 68. Qiagen Profiles
Table 69. Qiagen Lung Cancer Liquid Biopsy Product Introduction
Table 70. Qiagen Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Qiagen Strategic initiatives
Table 72. Guardant Health Profiles
Table 73. Guardant Health Lung Cancer Liquid Biopsy Product Introduction
Table 74. Guardant Health Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Guardant Health Strategic initiatives
Table 76. MDxHealth Profiles
Table 77. MDxHealth Lung Cancer Liquid Biopsy Product Introduction
Table 78. MDxHealth Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. MDxHealth Strategic initiatives
Table 80. Pathway Genomics Profiles
Table 81. Pathway Genomics Lung Cancer Liquid Biopsy Product Introduction
Table 82. Pathway Genomics Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Pathway Genomics Strategic initiatives
Table 84. NeoGenomics Laboraories Profiles
Table 85. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Product Introduction
Table 86. NeoGenomics Laboraories Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. NeoGenomics Laboraories Strategic initiatives
Table 88. Sysmex Inostics Profiles
Table 89. Sysmex Inostics Lung Cancer Liquid Biopsy Product Introduction
Table 90. Sysmex Inostics Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Sysmex Inostics Strategic initiatives
Table 92. Cynvenio Profiles
Table 93. Cynvenio Lung Cancer Liquid Biopsy Product Introduction
Table 94. Cynvenio Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Cynvenio Strategic initiatives
Table 97. Menarini Silicon Biosystems Profiles
Table 98. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Product Introduction
Table 99. Menarini Silicon Biosystems Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Menarini Silicon Biosystems Strategic initiatives
Table 101. Adaptive Biotechnologies Profiles
Table 102. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Product Introduction
Table 103. Adaptive Biotechnologies Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Adaptive Biotechnologies Strategic initiatives
Table 105. Biocept Profiles
Table 106. Biocept Lung Cancer Liquid Biopsy Product Introduction
Table 107. Biocept Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Biocept Strategic initiatives
Table 109. Angle plc Profiles
Table 110. Angle plc Lung Cancer Liquid Biopsy Product Introduction
Table 111. Angle plc Lung Cancer Liquid Biopsy Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Angle plc Strategic initiatives
